Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study

Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study: Figure 1.

(2015) Darlisha A. Williams et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa

(2015) NP Govender et al.   HIV MEDICINE

Implementation and Operational Research

(2015) Lincoln Pac et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial

(2015) Sayoki Mfinanga et al.   LANCET

Point-of-Care Lateral Flow Assays for Tuberculosis and Cryptococcal Antigenuria Predict Death in HIV Infected Adults in Uganda

(2014) Yukari C. Manabe et al.   PLoS One

Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania

(2014) Kinanga A Magambo et al.   Journal of the International AIDS Society

Elucidating the immunological function of theCryptococcus neoformanscapsule

(2013) Anna Vecchiarelli et al.   Future Microbiology

Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam

(2013) Rachel M. Smith et al.   PLoS One

Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa

(2013) Joseph N. Jarvis et al.   PLoS One

Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update

(2013) The Southern African HIV Clinicians Society   SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE

Comparison of Four Assays for the Detection of Cryptococcal Antigen

(2012) M. J. Binnicker et al.   Clinical and Vaccine Immunology

Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa

(2012) Lukas Fenner et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme

(2010) Joseph N Jarvis et al.   AIDS

Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease?

(2010) Joseph N Jarvis et al.   AIDS

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

(2010) Joseph N Jarvis et al.   BMC INFECTIOUS DISEASES

In Vitro Connector Research

(2010) Cynthia Chernecky   CLINICAL INFECTIOUS DISEASES

Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited Settings

(2010) David B. Meya et al.   CLINICAL INFECTIOUS DISEASES

Efavirenz and bone health

(2009) Gianluigi Fabbriciani et al.   AIDS

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Cause‐Specific Mortality and the Contribution of Immune Reconstitution Inflammatory Syndrome in the First 3 Years after Antiretroviral Therapy Initiation in an Urban African Cohort

(2009) Barbara Castelnuovo et al.   CLINICAL INFECTIOUS DISEASES

Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa

(2009) Joseph N. Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

(2008) Stephen D Lawn et al.   AIDS